F. Knox

发表

Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status

A. Howell, D. Evans, F. Lalloo, 2010, British Journal of Cancer.

Epithelial proliferation and hormone receptor status in the normal post-menopausal breast and the effects of hormone replacement therapy.

C. Potten, R. Swindell, N. Bundred, 1998, British Journal of Cancer.

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing

E A Jones, A Howell, A. Howell, 2009, Journal of Medical Genetics.

Central Review of ER, PgR and HER2 in BIG 1-98 Evaluating Letrozole vs. Letrozole Followed by Tamoxifen vs. Tamoxifen Followed by Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer.

A. Giobbie-Hurder, P. Neven, A. Goldhirsch, 2009 .

Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity

C. Dive, H. Kawakatsu, R. Swindell, 2006, British Journal of Cancer.

Expression of the receptor for parathyroid hormone‐related protein in normal and malignant breast tissue

A. Freemont, J. Hoyland, N. Bundred, 1997, The Journal of pathology.

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from trial BIG 1-98 comparing adjuvant endocrine therapy with tamoxifen versus letrozole

A. Giobbie-Hurder, P. Neven, B. Gusterson, 2008 .

Malignant fibrous histiocytomas of salivary glands

H. Fox, F. Knox, E. Benjamin, 1982, Journal of clinical pathology.

Apparent monoclonal origin of lymphocytes and plasma cells infiltrating ocular adnexal amyloid deposits: report of 2 cases.

D. Lucas, F. Knox, S. Davies, 1982, The British journal of ophthalmology.

Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.

Jack Cuzick, Valerie Speirs, Mitch Dowsett, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.

A. Giobbie-Hurder, P. Neven, R. Gelber, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial

C. Woodman, C. Boggis, P. Hopwood, 2018 .

Idiopathic granulomatous mastitis: a 25-year experience.

N. Bundred, F. Knox, B. Al-Khaffaf, 2008, Journal of the American College of Surgeons.

Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo

Julie Morris, F. Wärnberg, R. Clarke, 2006, Breast Cancer Research.

Impact of a national external quality assessment scheme for breast pathology in the UK

I. Ellis, S. Humphreys, S. Pinder, 2006, Journal of Clinical Pathology.

The NHS breast screening programme (pathology) EQA: experience in recent years relating to issues involved in individual performance appraisal

I. Ellis, S. Humphreys, S. Pinder, 2006, Journal of Clinical Pathology.

Can preoperative factors predict for residual malignancy after breast biopsy for invasive cancer?

R. Mansel, N. Bundred, A. Baildam, 1995, Annals of the Royal College of Surgeons of England.

CLINICAL TRIALS IN LATIN AMERICA

Richard J. K. Taylor, F. Knox, 1999 .

A comparison of axillary node status between cancers detected at the prevalence and first incidence breast screening rounds.

F. Knox, J. Walls, C. Boggis, 1996, British Journal of Cancer.